SCYNEXIS Inc SCYX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:25 PM EDT
1.75quote price arrow down-0.02 (-1.13%)
Volume
100,044
52 week range
1.35 - 3.87
Loading...
  • Open1.79
  • Day High1.79
  • Day Low1.72
  • Prev Close1.77
  • 52 Week High3.87
  • 52 Week High Date09/05/23
  • 52 Week Low1.35
  • 52 Week Low Date03/19/24

Key Stats

  • Market Cap66.115M
  • Shares Out37.78M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta1.45
  • YTD % Change-21.08

KEY STATS

  • Open1.79
  • Day High1.79
  • Day Low1.72
  • Prev Close1.77
  • 52 Week High3.87
  • 52 Week High Date09/05/23
  • 52 Week Low1.35
  • 52 Week Low Date03/19/24
  • Market Cap66.115M
  • Shares Out37.78M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta1.45
  • YTD % Change-21.08

RATIOS/PROFITABILITY

  • EPS (TTM)1.29
  • P/E (TTM)1.35
  • Fwd P/E (NTM)-10.29
  • EBITDA (TTM)73.249M
  • ROE (TTM)175.97%
  • Revenue (TTM)140.142M
  • Gross Margin (TTM)88.85%
  • Net Margin (TTM)47.84%
  • Debt To Equity (MRQ)16.66%

EVENTS

  • Earnings Date05/08/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On SCYNEXIS Inc

 

Profile

MORE
SCYNEXIS, Inc. is a biotechnology company. It is pioneering medicine to overcome and prevent difficult-to-treat and drug-resistant infections. It develops antifungal platform fungerps, a novel class of antifungal agents called triterpenoids, that are structurally distinct glucan synthase inhibitors and have generally shown in vitro and in vivo activity against a range of human fungal pathogens, such as Candida and Aspergillus genera, including multidrug-resistant strains, and...
Guy Macdonald
Non-Executive Independent Chairman of the Board
David Angulo M.D.
President, Chief Executive Officer, Director
Ivor Macleod CPA
Chief Financial Officer
Scott Sukenick J.D.
General Counsel
Address
1 Evertrust Plaza, 13Th Floor
Jersey City, NJ
07302-6548
United States

Top Peers

SYMBOLLASTCHG%CHG
ASRT
Assertio Holdings Inc
1.07+0.04+3.88%
ACORQ
Acorda Therapeutics Inc
0.80-0.05-5.8824%
AYTU
Aytu Biopharma Inc
3.10+0.10+3.16%
MEIP
MEI Pharma Inc
3.19+0.13+4.25%
OPTN
OptiNose Inc
1.17+0.16+15.84%